After more than a decade of research, a new-generation CAR-T therapy developed by VHIO, in collaboration with the Hospital del…
Breast Cancer Research Foundation
Researchers from the Hospital del Mar Research Institute and the VHIO’s Growth Factors Group have demonstrated, in animal models, the…
The p95HER2 protein is found expressed in one third of HER2+ tumors, which represent 4% of all tumors. Led by…
The Breast Cancer Research Foundation (BCRF) is investing $70.3 million—BCRF’s largest annual program in its 31-year history— to fund breast…
The Breast Cancer Research Foundation (BCRF) will commit $60.2 million to breast cancer research in 2023-2024, supporting more than 250…
